Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market
HYDERABAD (Reuters) -Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous
In the Market: How Trump is driving Asia to diversify away from US
-President Donald Trump's tariffs and other policies have some financiers and officials in Asia predicting the remaking of the post-World War II economic order, leading to an urgent quest to diversify
Commerce Secretary Howard Lutnick hawks Tesla stock on TV: 'It'll never be this cheap again'
"It's unbelievable that this guy's stock is this cheap. It'll never be this cheap again," Lutnick said of Elon Musk's EV company, Tesla.
7 reasons one analyst says it's time to buy Tesla after its stock crash
Cantor analysts said their bullishness on Tesla crystallized after they visited the company's Gigafactory and AI data centers in Austin, Texas.
U.S. stocks rise, dollar strengthens as strong data counters central banks' caution
NEW YORK (Reuters) -U.S. stocks extended their rally and the dollar strengthened as solid data helped investors look past notes of caution from world central bank leaders regarding mounting economic u
US households are sitting on record amounts of stock. That could be bad news for the market.
"With this much optimism, one must ask how much liquidity is left around to buy," Ned Davis Research said.
Watch These AppLovin Price Levels as AI Stock's Volatile Run Continues
AppLovin shares surged Wednesday as investors reassessed their positions in the AI-powered advertising platform after selling accelerated in the stock yesterday. Monitor these crucial chart levels.